NCT00657332

Brief Summary

This research involves the study of neuroendocrine tumors in order to better understand how the disease grows and spreads. This study requires will use tissue collected from from biopsies performed during your regular medical care (i.e. tissue leftover after your diagnosis has been made) and/or blood and urine samples. This study may lead to the development of special materials that could be used, in the future, to treat neuroendocrine tumors or to follow the response of neuroendocrine tumors to treatment

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2007

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 14, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2008

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

12 months

First QC Date

April 9, 2008

Last Update Submit

November 21, 2023

Conditions

Carcinoid TumorNeuroendocrine Tumors

Interventions

blood sample drawPROCEDURE
urine samplePROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

neuroendocrine tumor patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

biopsy of tumor, blood sample and/or urine samples.

MeSH Terms

Conditions

Carcinoid TumorNeuroendocrine Tumors

Condition Hierarchy (Ancestors)

Neuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms, Nerve Tissue

Study Officials

  • George Albert Fisher M.D. Ph.D.

    Stanford University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 9, 2008

First Posted

April 14, 2008

Study Start

July 1, 2007

Primary Completion

June 17, 2008

Study Completion

June 17, 2008

Last Updated

November 28, 2023

Record last verified: 2023-11